NCT04887467View on ClinicalTrials.gov

Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

June 22, 2024

Study Completion Date

July 22, 2024

Conditions

Parkinson Disease

Interventions

DRUG

Apomorphine

"Assigned Interventions:~* blood sampling~* blood collection~* systolic, diastolic, mean blood pressure and heart rate measure"

Trial Locations (1)

35033

CHU Pontchaillou, Rennes

All Listed Sponsors

lead

Rennes University Hospital

OTHER

NCT04887467 - Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter